14-3-3 γ induces oncogenic transformation by stimulating MAP kinase and PI3K signaling

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Radhakrishnan, Vijayababu M ^a   Martinez, Jesse D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

H RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN 14 3 3; PROTEIN 14 3 3 GAMMA; RAF PROTEIN; RAS PROTEIN; STRATIFIN; TENASCIN; TUBERIN; UNCLASSIFIED DRUG; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST CULTURE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL TRANSFORMATION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN BINDING;

MUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 14-3-3 PROTEINS; ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; IMMUNOPRECIPITATION; MICE; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASES; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION;

EID: 77955373300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011433     Document Type: Article

References (41)

1. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889-897.
2. Morrison DK (2009) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19: 16-23.
3. Li S, Janosch P, Tanji M, Rosenfeld GC, Waymire JC, et al. (1995) Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. Embo J 14: 685-696.
4. Samuel T, Weber HO, Rauch P, Verdoodt B, Eppel JT, et al. (2001) The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax. J Biol Chem 276: 45201-45206.
5. Su TT, Parry DH, Donahoe B, Chien CT, O'Farrell PH, et al. (2001) Cell cycle roles for two 14-3-3 proteins during Drosophila development. J Cell Sci 114: 3445-3454.
6. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, et al. (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277: 1501-1505.
7. Hermeking H (2003) The 14-3-3 cancer connection. Nat Rev Cancer 3: 931-943.
8. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, et al. (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 97: 6049-6054.
9. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, et al. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11.
10. Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, et al. (2009) 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 16: 195-207.
11. Fan T, Li R, Todd NW, Qiu Q, Fang HB, et al. (2007) Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 67: 7901-7906.
12. Guweidhi A, Kleeff J, Giese N, El Fitori J, Ketterer K, et al. (2004) Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 25: 1575-1585.
13. Qi W, Liu X, Qiao D, Martinez JD (2005) Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113: 359-363.
14. Jin YH, Kim YJ, Kim DW, Baek KH, Kang BY, et al. (2008) Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem Biophys Res Commun 368: 690-695.
15. Bondy GP, Wilson S, Chambers AF (1985) Experimental metastatic ability of Hras-transformed NIH3T3 cells. Cancer Res 45: 6005-6009.
16. Ray RB, Steele R, Seftor E, Hendrix M (1995) Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res 55: 3747-3751.
17. Morrison DK (1995) Activation of Raf-1 by Ras in intact cells. Methods Enzymol 255: 301-310.
18. Ballare E, Persani L, Lania AG, Filopanti M, Giammona E, et al. (2001) Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab 86: 3809-3814.
19. Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K (1996) Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J Biol Chem 271: 29342-29346.
20. Takihara Y, Matsuda Y, Hara J (2000) Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 21: 2073-2077.
21. Qi W, Liu X, Chen W, Li Q, Martinez JD (2007) Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. Mol Carcinog 46: 847-856.
22. Tuck SP, Crawford L (1989) Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion. Oncogene Res 4: 81-96.
23. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, et al. (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371: 612-614.
24. Olson MF, Marais R (2000) Ras protein signalling. Semin Immunol 12: 63-73.
25. Li W, Zhu T, Guan KL (2004) Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J Biol Chem 279: 37398-37406.
26. Munday AD, Berndt MC, Mitchell CA (2000) Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta. Blood 96: 577-584.
27. Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, et al. (2006) Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173: 279-289.
28. Tzivion G, Avruch J (2002) 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 277: 3061-3064.
29. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, et al. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970.
30. Zhao L, Vogt PK (2008) Class I PI3K in oncogenic cellular transformation. Oncogene 27: 5486-5496.
31. Michaud NR, Fabian JR, Mathes KD, Morrison DK (1995) 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras-independent manner. Mol Cell Biol 15: 3390-3397.
32. Li Y, Inoki K, Yeung R, Guan KL (2002) Regulation of TSC2 by 14-3-3 binding. J Biol Chem 277: 44593-44596.
33. Liu MY, Cai S, Espejo A, Bedford MT, Walker CL (2002) 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). Cancer Res 62: 6475-6480.
34. Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223-1233.
35. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179-193.
36. Dan HC, Sun M, Yang L, Feldman RI, Sui XM, et al. (2002) Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 277: 35364-35370.
37. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657.
38. Potter CJ, Pedraza LG, Xu T (2002) Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4: 658-665.
39. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, et al. (2000) Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19: 5298-5302.
40. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, et al. (2002) Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417: 871-875.
41. Yang H, Wen YY, Zhao R, Lin YL, Fournier K, et al. (2006) DNA damageinduced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 66: 3096-3105.